primari
immunodefici
pid
phenotyp
genet
heterogen
group
monogen
inherit
disord
result
immun
defect
predispos
patient
infect
autoimmun
disord
lymphoprolif
diseas
malign
pid
sever
phenotyp
lead
lifethreaten
infect
lifelimit
complic
requir
prompt
accur
diagnosi
order
initi
lifesav
therapi
phenotyp
genotyp
heterogen
pid
make
genet
diagnosi
often
complex
delay
inde
one
genotyp
might
caus
similar
clinic
phenotyp
ident
genotyp
often
produc
phenotyp
final
clinic
penetr
may
differ
character
pidassoci
gene
expect
significantli
contribut
defin
molecular
event
govern
immun
system
develop
provid
new
insight
pathogenesi
pid
molecular
genet
test
also
use
tool
diagnosi
pid
atyp
case
despit
progress
genet
character
pid
mani
patient
still
lack
molecular
diagnosi
better
understand
genet
immun
defect
patient
critic
develop
therapeut
strategi
aim
chang
clinic
cours
diseas
guarante
appropri
genet
counsel
allow
identif
pid
patient
onset
diseas
applic
next
gener
sequenc
ng
pid
revolut
acceler
discoveri
identif
novel
diseasecaus
gene
genet
diagnosi
patient
monogen
inborn
error
immun
target
genepanel
sequenc
whole
exom
sequenc
we
whole
genom
sequenc
wg
approach
rapidli
identifi
candid
gene
variant
increas
number
genet
undefin
diseas
wide
use
sever
laboratori
diagnosi
pid
wg
also
offer
opportun
find
caus
variant
structur
region
given
gene
tool
increas
amount
data
analysi
identifi
caus
gene
clinic
defin
atyp
diseas
nonetheless
delay
diagnosi
caus
huge
amount
data
retriev
whole
sequenc
increas
cost
sustain
clinic
laboratori
requir
train
personnel
valid
variant
increas
depth
sequenc
coverag
gener
obtain
use
target
gene
panel
favor
high
accuraci
amelior
sensit
manag
dataset
reduc
time
analysi
cost
interpret
result
thu
acceler
diagnosi
major
pid
hand
use
target
exom
sequenc
approach
identif
pid
patient
demonstr
accur
detect
point
mutat
exon
delet
patient
either
known
unknown
genet
diagnosi
studi
report
clinic
molecular
character
pid
patient
present
either
typic
scidcid
overlap
pid
phenotyp
differ
studi
patient
enrol
work
nonconsanguin
parent
two
target
sequenc
approach
compar
test
ion
torrent
reliabl
diagnost
haloplex
target
enrich
system
diagnost
research
purpos
three
diagnost
panel
includ
known
diseas
gene
develop
ion
torrent
platform
thermofish
haloplex
panel
compris
welldefin
pid
gene
candid
gene
associ
pid
due
express
function
critic
immunepathway
work
underlin
target
ng
panel
allow
highthroughput
lowcost
pipelin
identifi
molecular
base
pid
sensit
accur
diagnost
tool
simultan
mutat
screen
known
put
pidrel
gene
report
clinic
molecular
character
pid
patient
mainli
refer
three
center
rome
milan
particip
italian
network
pid
ipinet
part
european
refer
network
immunodefici
autoinflammatori
autoimmun
diseas
ern
rita
nine
patient
enrol
pcid
studi
data
obtain
year
ion
torrent
andor
haloplex
panel
appli
analysi
sampl
compar
six
patient
previous
diagnos
sanger
sequenc
includ
studi
tabl
intern
posit
control
ion
torrent
panel
use
analysi
patient
suspicion
pid
among
group
patient
still
remain
without
molecular
diagnosi
addit
patient
test
haloplex
panel
target
enrich
system
illumina
platform
work
conduct
accord
ethic
standard
institut
research
committe
helsinki
declar
later
amend
compar
ethic
standard
inform
consent
approv
ethic
committe
children
hospit
bambino
san
raffael
hospit
policlinico
tor
vergata
obtain
either
patient
parentsleg
guardian
minor
patient
clinic
immunolog
featur
report
tabl
construct
target
panel
design
requir
studi
sever
report
clinic
phenotyp
known
pid
gene
describ
iui
intern
union
immunolog
societi
year
three
custom
ion
torrent
panel
design
ampliseq
design
softwar
use
panel
panel
refer
primer
divid
two
pool
first
custom
panel
panel
contain
known
gene
relat
scidcid
phenotyp
kb
second
custom
panel
panel
includ
gene
less
frequent
cid
phenotyp
kb
third
panel
panel
includ
gene
cvid
kb
supplementari
tabl
final
design
expect
cover
first
panel
second
panel
third
gene
panel
gene
includ
panel
bp
exon
pad
includ
cover
flank
region
exon
code
sequenc
cd
includ
panel
panel
untransl
region
utr
dna
extract
qiaamp
dna
blood
mini
kit
qiagen
five
nanogram
gdna
use
librari
prepar
dna
amplifi
amplif
cycl
use
gene
panel
primer
pool
ampliseq
hifi
mix
thermo
fisher
pcr
pool
sampl
combin
subject
primer
digest
fupa
reagent
thermo
fisher
librari
index
use
ion
xpress
barcod
adapt
kit
purif
amplifi
librari
quantifi
fluoromet
sampl
dilut
final
concentr
pm
amplicon
librari
pool
emuls
pcr
epcr
ion
onetouch
system
use
ion
pgm
templat
kit
ion
chef
accord
manufactur
instruct
qualiti
control
librari
perform
fluoromet
ampliseq
design
sampl
subject
standard
ion
pgm
sequenc
protocol
use
ion
chip
ion
use
ion
chip
life
technolog
map
variant
call
perform
use
ion
torrent
suit
softwar
sequenc
read
align
panel
panel
refer
genom
use
program
distribut
within
torrent
map
align
program
tmap
algorithm
thermo
fisher
http
githubcomion
torrentt
align
step
limit
region
target
gene
bam
file
align
read
process
variant
call
torrent
suit
variant
caller
tvc
program
variant
variant
call
format
vcf
file
annot
annovar
call
variant
minimum
coverag
standard
map
qualiti
base
phred
qualiti
examin
integr
genom
viewer
igv
biomart
filter
procedur
select
variant
minor
allel
frequenc
maf
annot
use
follow
public
databas
genom
project
sampl
http
exom
variant
server
esp
we
sampl
http
evsgswashingtoneduev
exom
aggreg
consortium
exac
sampl
http
exacbroadinstituteorg
nonsens
frameshift
start
lost
stop
lost
canon
splice
site
variant
consid
potenti
pathogen
silico
predict
function
consequ
novel
snv
perform
use
mutat
taster
ltr
sift
cadd
score
literatur
avail
data
supplementari
figur
summar
step
process
design
two
panel
includ
known
pid
gene
chosen
custom
gene
target
panel
agil
suredesign
onlin
tool
http
candid
addit
gene
taken
rapid
web
site
http
rapidrcairikenjp
riken
center
integr
medic
scienc
literatur
esid
onlin
registri
candid
gene
categori
includ
gene
might
found
clinic
relev
pid
pathway
share
similar
biolog
function
known
pid
gene
first
panel
target
gene
compris
region
amplicon
second
panel
target
gene
includ
region
amplicon
design
probe
captur
flank
base
code
exon
region
supplementari
tabl
b
final
probe
design
expect
cover
target
region
practic
coverag
indic
genom
dna
extract
qiaamp
dna
blood
mini
kit
qiagen
quantifi
qubit
dsdna
br
assay
kit
thermofish
dna
integr
check
agaros
gel
agaros
tae
genom
dna
enrich
haloplex
target
enrich
system
kit
agil
technolog
inc
germani
librari
prepar
accord
manufactur
instruct
briefli
ng
genom
dna
enzymat
digest
fragment
hybrid
conjug
biotin
probe
h
circular
target
dnahaloplex
probe
hybrid
captur
streptavidinco
magnet
bead
dna
ligas
ad
captur
reaction
close
nick
circular
probetarget
dna
hybrid
dna
sampl
individu
index
hybrid
step
librari
pcr
amplif
perform
mastercycl
nexu
thermal
cycler
life
scienc
biotechnolog
hamburg
germani
amplicon
purifi
ampur
xp
bead
beckman
coulter
inc
krefeld
germani
sequenc
perform
miseq
reagent
kit
cycl
pm
sampl
librari
load
illumina
miseq
san
diego
ca
usa
qualiti
control
fragment
final
concentr
prepar
librari
assess
bioanalyz
agil
technolog
inc
eindhoven
netherland
fastq
file
align
human
refer
genom
ucsc
align
picard
hsmetric
appli
analyz
targetcaptur
sequenc
experi
http
picardsourceforgenet
intern
script
use
calcul
mean
gene
coverag
variant
call
perform
freebay
raw
variant
filter
follow
paramet
qual
qualao
saf
sar
rpr
rpl
variant
allel
depth
read
exclud
analysi
select
variant
annot
clinvar
dbnsfp
databas
snpeff
filter
common
allel
frequenc
caf
variant
effect
exon
missens
frameshift
splice
acceptordonor
start
lost
stop
lost
stop
gain
variant
found
either
utr
exclud
subsequ
analys
silico
analysi
variant
pathogen
determin
accord
predict
tool
mutat
taster
ltr
sift
cadd
score
case
trio
variant
subdivid
accord
model
inherit
autosom
recessivedomin
xlink
de
novo
complet
bioinformat
analysi
report
supplementari
figur
data
analyz
graphpad
prism
version
graph
pad
softwar
la
jolla
ca
studi
report
clinic
molecular
character
pid
patient
present
either
typic
overlap
pid
phenotyp
patient
cluster
accord
initi
clinic
present
main
categori
figur
tcell
defect
includ
omenn
syndrom
scid
cid
syndrom
tcell
defect
unclassifi
tcell
defici
hyper
igm
syndrom
humor
defect
agammaglobulinemia
cvid
unclassifi
antibodi
defici
dysgammaglobulinemia
pid
immun
dysregul
innat
immun
defect
includ
congenit
defect
phagocyt
syndrom
defect
immunedefici
signssymptom
alpsalpslik
autoinflammatori
syndrom
miscellan
includ
nontyp
pid
patient
broad
rang
clinic
phenotyp
clinic
immunolog
molecular
featur
report
tabl
percentag
patient
subgroup
shown
figur
among
tcell
defect
n
major
patient
present
scid
follow
cid
figur
humor
defect
group
n
mainli
repres
cvid
pid
group
n
includ
wide
spectrum
rare
defect
uncommon
phenotyp
seventythre
pid
patient
analyz
ion
torrent
sequenc
system
use
three
differ
panel
includ
scidcid
cvid
known
gene
two
haloplex
panel
includ
known
candid
pid
gene
appli
addit
patient
addit
patient
previous
analyz
ion
torrent
still
without
clear
molecular
diagnosi
analyz
haloplex
system
flow
chart
show
rout
map
sequenc
index
patient
shown
figur
mean
target
coverag
result
panel
panel
panel
ion
torrent
haloplex
panel
supplementari
figur
mean
target
coverag
ion
torrent
panel
optim
compar
recent
publish
work
coverag
obtain
inde
ion
torrent
expect
coverag
code
region
panel
scidcid
panel
rare
cid
panel
supplementari
tabl
practic
coverag
obtain
ion
torrent
panel
shown
supplementari
figur
primer
design
haloplex
aim
cover
code
region
gene
observ
coverag
target
region
run
two
panel
repres
supplementari
tabl
b
major
share
gene
includ
panel
analyz
technolog
wellcov
supplementari
figur
use
larg
panel
ng
retriev
big
number
data
compar
small
panel
put
variant
detect
ion
torrent
examin
valid
obtain
averag
fals
posit
variant
valu
decreas
reduc
number
gene
includ
panel
haloplex
produc
larger
amount
variant
one
significantli
indic
among
relat
patient
phenotyp
investig
henc
could
properli
evalu
data
accuraci
patient
resequenc
haloplex
variant
gene
includ
ion
torrent
panel
found
support
accuraci
method
furthermor
avail
sampl
previous
diagnos
sanger
sequenc
known
differ
mutat
gene
includ
studi
detect
ion
torrent
panel
tabl
one
fals
neg
diagnosi
recent
recogn
inde
torrent
suit
variant
caller
tvc
program
unabl
identifi
mutat
exon
gene
patient
detect
igv
cohort
molecular
diagnosi
obtain
figur
sanger
sequenc
mutat
parent
carrier
statu
perform
function
studi
conduct
novel
variant
result
report
tabl
rapid
molecular
diagnosi
establish
pid
patient
investig
ion
torrent
diagnos
achiev
ada
xiap
gene
see
tabl
expect
identif
molecular
defect
result
frequent
patient
clear
clinic
immunolog
phenotyp
shown
includ
group
cell
defect
figur
interestingli
percentag
diagnosi
group
scidcid
patient
percentag
molecular
diagnosi
patient
studi
haloplex
panel
shown
figur
first
diagnos
obtain
cohort
patient
three
scidcid
patient
mutat
gene
volpi
et
al
revis
diagnos
cell
defect
moreov
nra
gene
associ
complex
phenotyp
identifi
pid
group
figur
two
addit
patient
diagnos
analyz
patient
previous
neg
ion
torrent
present
less
defin
immunolog
phenotyp
figur
one
patient
ion
torrent
panel
abl
detect
missens
mutat
ada
gene
haloplex
identifi
second
intron
mutat
locat
fifth
nucleotid
upstream
exon
includ
ion
torrent
design
gene
second
ion
torrent
neg
patient
present
atyp
hyperig
syndrom
haloplex
detect
two
rare
homozyg
mutat
gene
includ
ion
torrent
panel
pathogen
role
singl
gene
mutat
still
investig
molecular
inform
import
optim
clinic
manag
patient
includ
evalu
hsct
definit
treatment
summari
scidcid
patient
total
cell
defect
identifi
haloplex
demonstr
higher
percentag
diagnosi
pid
group
tabl
howev
although
possibl
identifi
caus
gene
mutat
correl
precis
clinic
cluster
identif
patient
complex
extend
phenotyp
need
larger
ng
panel
compar
result
obtain
two
method
ion
torrent
haloplex
diseaseassoci
variant
identifi
patient
novel
tabl
major
variant
detect
ion
torrent
missens
n
summar
figur
also
abl
detect
small
delet
splice
site
variant
haloplex
panel
detect
missens
delet
splice
site
stop
codon
variant
figur
among
diagnos
patient
found
compound
heterozyg
patient
mutat
ada
gene
homozyg
variant
includ
ada
hemizyg
variant
xiap
heterozyg
somat
variant
nra
figur
therefor
patient
enrol
studi
offspr
nonconsanguin
marriag
frequent
mutat
gene
cohort
follow
figur
fifteen
cvid
patient
initi
analyz
ion
torrent
panel
caus
variant
found
therefor
design
specif
cvid
panel
found
put
caus
variant
suggest
ad
diseas
confirm
sanger
sequenc
inde
found
heterozyg
damag
variant
gene
predict
damag
variant
pten
gene
adult
patient
follow
sinc
childhood
patient
inherit
one
mutat
father
one
mother
real
role
variant
possibl
combin
effect
still
investig
addit
two
vu
gene
found
two
patient
evid
avail
see
tabl
rare
variant
gene
found
patient
exclud
analysi
although
alter
express
detect
variant
predict
benign
multipl
databas
furthermor
homozyg
rare
variant
gene
found
patient
howev
two
proband
healthi
brother
found
homozyg
variant
thu
consid
pathogen
nevertheless
addit
function
studi
perform
exclud
genet
predisposit
eg
activ
protein
express
three
novel
variant
uncertain
signific
vu
identifi
haloplex
patient
classic
complex
phenotyp
still
investig
current
valid
novel
damag
variant
gene
two
twin
patient
mother
affect
cvid
emsa
assay
ongo
assess
capac
protein
bind
dna
target
sequenc
twin
patient
also
previous
found
sanger
sequenc
mutat
gene
alreadi
describ
associ
cvid
caus
variant
gene
sever
myopia
ectoderm
dysplasia
cytopenia
found
patient
alter
immunolog
phenotyp
remain
poorli
explain
mutat
moreov
variant
cid
patient
found
signific
still
investig
final
heterozyg
variant
gene
found
haloplex
three
patient
gener
variant
suscept
gene
involv
diseas
pathogenesi
consid
potenti
futur
phenotyp
implic
particularli
adult
patient
multipl
factor
may
contribut
onset
diseas
applic
multigen
ng
panel
extend
knowledg
pid
current
recogn
comprehens
diagnost
method
field
rare
disord
consent
diagnosi
case
depend
pid
clinic
phenotyp
cluster
present
work
show
complementari
integr
use
two
custommad
target
sequenc
approach
ion
torrent
haloplex
allow
clearli
identifi
caus
variant
n
patient
group
pid
confirm
valu
ng
assay
obtain
genet
diagnosi
pid
ion
torrent
approach
result
highli
success
scid
patient
group
gener
defin
immunolog
clinic
present
inde
approach
identifi
scidcid
patient
haloplex
workflow
abl
identifi
caus
variant
patient
found
group
scidcid
patient
fall
complex
extend
phenotyp
interestingli
molecular
diagnosi
achiev
patient
present
typic
atyp
clinic
phenotyp
result
neg
ion
torrent
analysi
includ
haloplex
approach
ng
possibl
identifi
unexpect
mutat
appar
correspond
pid
case
recent
report
group
patient
agammaglobulinemia
due
defici
result
strengthen
notion
larg
phenotyp
varieti
associ
rag
defici
suggest
consid
also
patient
present
isol
mark
bcell
defect
alreadi
report
rag
mutat
frequent
expect
notabl
frequent
pid
caus
cohort
case
repres
paradigmat
model
new
question
aris
manag
followup
patient
milder
phenotyp
could
associ
altern
treatment
transplant
cvid
typic
exampl
diseas
broad
phenotyp
due
differ
gene
alter
notabl
cvid
patient
mutat
air
previous
detect
sanger
sequenc
see
tabl
extend
ng
analysi
look
novel
diseas
caus
gene
therefor
frequent
variant
compar
polymorph
consid
caution
sinc
pathogen
mean
still
unclear
addit
function
studi
case
requir
four
addit
diagnos
summar
supplementari
tabl
obtain
complet
present
studi
target
ng
panel
sanger
sequenc
indic
combin
indepth
clinic
knowledg
appropri
sequenc
techniqu
lead
new
diagnos
although
priorit
method
appli
studi
follow
common
assumpt
correct
data
analysi
identif
novel
variant
current
investig
repres
challeng
valid
need
essenti
support
indepth
experiment
studi
integr
clinic
immunolog
biochem
molecular
data
might
favor
revis
pid
classif
patient
similar
phenotyp
due
differ
genet
caus
patient
differ
phenotyp
genet
caus
experi
use
select
ng
panel
use
easi
handl
rapid
diagnosi
clinic
immunolog
wellcharacter
phenotyp
compar
we
target
small
ng
panel
provid
import
altern
clinician
direct
sequenc
relev
gene
guarante
high
coverag
sequenc
depth
contrari
applic
patient
atyp
phenotyp
could
result
incomplet
delay
diagnosi
extend
gene
panel
we
directli
use
case
research
purpos
allow
diagnosi
unexpect
genotypephenotyp
associ
report
sever
group
applic
target
we
suspicion
pid
explor
genebygen
also
limit
number
strike
gene
still
remain
time
resourc
consum
absenc
synergi
clinic
bioinformat
support
yet
unfeas
extend
diagnost
purpos
inde
huge
amount
retriev
data
risk
incident
find
nonpid
gene
involv
differ
monogen
multifactori
patholog
may
confound
correspond
first
suspicion
addit
confid
result
decreas
number
target
gene
may
preclud
variant
detect
selfevid
known
gene
mani
previous
undetect
variant
welldefin
role
genom
million
variant
genom
lesser
exom
scenario
ethic
legal
issu
relat
disclosur
genet
inform
gener
ng
need
consid
guidelin
develop
help
differ
specialist
translat
genet
result
clinic
achiev
ng
applic
requir
integr
knowledg
base
clinic
immunolog
molecular
data
collabor
among
differ
expert
field
better
clinic
immunolog
genet
character
new
pid
significantli
contribut
identif
diagnost
prognost
marker
earli
individu
therapeut
strategi
signific
patient
benefit
data
upload
clinvar
access
number
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
